reboxetine


Also found in: Dictionary, Thesaurus, Wikipedia.

reboxetine

A selective NORADRENALINE REUPTAKE INHIBITOR antidepressant drug. A brand name is Edronax.
Mentioned in ?
References in periodicals archive ?
Effects of reboxetine on Hamilton Depression Rating Scale factors from randomized, placebo-controlled trials in major depression.
org/content/vo151/issue9/), reboxetine, pipamperone, and norclozapine had retention times similar to that for aripiprazole.
Eight randomized, studies with efficacy data from 1,959 inpatients and outpatients with major depressive disorder found that reboxetine compared favorably with desipramine, imipramine, fluoxetine, and placebo, which led to its approval in other countries.
Forty patients were on a tricyclic antidepressant; the others were roughly evenly divided between mirtazapine, reboxetine, venlafaxine, quetiapine, and SSRIs.
Adolescents aged 15 [less than or equal to] 19 years yet again received a number of antidepressants not recommended or indicated for use in this age group, for example, bupropion, dothiepin, duloxetine, escitalopram, flupenthixol, lofepramine, mirtazapine, moclobemide, paroxetine, reboxetine, and venlafaxine (see Table 1).
Corrigan has been involved in the development of several drugs including Estorra(TM) for the treatment of insomnia, Xopenex(R) for the treatment of bronchospasm, such as asthma, Mirapex for the treatment of Parkinson's disease, Delavirdine for AIDS, Cycloprovera for birth control, Xalatan for glaucoma, Camptosar for colorectal cancer and Reboxetine for depression.
The antidepressant reboxetine is likely to receive full Food and Drug Administration approval by the end of the year.
4 Nefazodone, Moclobemide, Reboxetine and Trazodone 111
The review looked at the following drugs: bupropion, citalopram (Celexa), duloxetine (Cymbalta), escitalopram (Lexapro), fluoxetine, fluvoxamine (Luvox), milnacipran, mirtazapine (Remeron), paroxetine (Paxil), reboxetine, sertraline (Zoloft), and venlafaxine (Effexor) (Lancet 2009 [doi: 10.
Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.
This group includes three Phase III programs, valuable potential new indications for market-leaders Celebrex and Lyrica, and trials of S,S reboxetine for fibromyalgia.
Improvement of these symptoms, according to recent study findings of the new, investigational, norepinephrine-specific antidepressant reboxetine, might lead to improvement in social functioning and be beneficial to patients.